P Values and Multiple Endpoints I: Pernicious Abstractions?
In a large clinical trial, thousands and sometimes tens of thousands of patients are followed for years. This effort generates hundreds of thousands of data points, carefully collected, verified, entered and analyzed by many workers, themselves committing thousands of hours to this task. Is all of this effort for just a single p value?
KeywordsPrimary Endpoint Secondary Endpoint Total Mortality Trial Endpoint Global Type
Unable to display preview. Download preview PDF.
- 6.Packer, M., Cohn, J.N., and Colucci, W.S. “Response to Moyé and Abernethy,” New England Journal of Medicine 335: 1318–1319.Google Scholar
- 8.Friedman, L., Furberg, C., and DeMets, D., (1996) Fundamentals of Clinical Trials, Third Edition, Mosby. Meinert, C.L., (1986) Clinical Trials Design, Conduct, and Analysis, Oxford University Press, New York.Google Scholar
- 9.Dowdy, S., Wearden, S., (1991) Statistics for Research, Second Edition, John Wiley and Sons, New York.Google Scholar
- 10.Dubey, S.D. “Adjustment of p values for multiplicities of interconnecting symptoms” in Statistics in the pharmaceutical industry Second Edition. Buncher, R.C. and Tsay, J.Y. Editors, Marcel Dekker Inc., New York.Google Scholar
- 11.Snedecor, G.W., Cochran, W.G., (1980), Statistical Methods Seventh Edition, Iowa State University Press, Iowa.Google Scholar
- 12.Gnosh, B.K., Sen, P.K. Handbook of Sequential Analysis,Marcel Dekker Inc., New York.Google Scholar
- 13.Miller, R.G., (1981) Simultaneous Statistical Inference Second Edition, Springer-Verlag, New York.Google Scholar
- 14.Anderson, T.W., (1984) An Introduction to Multivariate Statistical Analysis Second Edition, John Wiley and Sons, New York.Google Scholar